Roth MKM analyst Justin Clare lowered the firm’s price target on iSun to $0.50 from $1.00 but keeps a Buy rating on the shares. The company’s Q3 was a miss and the management also lowered its expectations for Q4 adjusted EBITDA due partly to a lower potential residential sales mix, the analyst tells investors in a research note. Valuation has been pressured by iSun’s convertible notes, but the company signed a term sheet for a non-dilutive $8M term loan expected to close near the end of November, and if the loan is secured, the company’s backlog could support further improvement in profitability in 2024, the firm added.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ISUN:
